Monitor the next USFDA re-inspection outcome at FTO-11 for potential impact on product approvals or manufacturing compliance. The two observations are not quantified, so no immediate read-through.
Price Chart
Executive Summary
Dr. Reddy's disclosed that the USFDA conducted a Pre-Approval Inspection (PAI) at its FTO-11 facility in Pydibhimavaram, Andhra Pradesh from October 5-7, 2026, resulting in a Form 483 with two observations. The company stated it will address the observations within the stipulated timeline. This is a routine regulatory disclosure with no material financial impact disclosed.
Key Facts
- USFDA completed a Pre-Approval Inspection (PAI) at Dr. Reddy's FTO-11 manufacturing facility in Pydibhimavaram, Andhra Pradesh from October 5 to October 7, 2026.
- The company received a Form 483 with two observations.
- Dr. Reddy's stated it will address the observations within the stipulated timeline.
- No financial figures, revenue impact, or material costs were disclosed in the filing.
Financial Impact
No financial impact disclosed; Form 483 with two observations is a routine regulatory outcome with no quantified exposure.
Risk Factors
- If observations are not adequately addressed, future USFDA actions could delay product approvals or lead to regulatory escalation.
- No specific remediation timeline or cost provided, creating uncertainty about resolution.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000683 |
| Document: 0001575872-26-000683-index.html | 0001575872-26-000683 |
| Document: 0001575872-26-000683.txt | 0001575872-26-000683 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 6-K | $13.65 | awaiting T+5 | — | $13.75 (+0.73%) |
Oct 26, 2026 today | 6-K | $13.65 | awaiting T+5 | — | $13.75 (+0.73%) |
Oct 23, 2026 3d ago | 6-K | $13.21 | awaiting T+5 | — | $13.75 (−4.09%) |
Oct 23, 2026 3d ago | 6-K | $13.21 | awaiting T+5 | — | $13.75 (+4.09%) |
Oct 23, 2026 3d ago | 6-K | $13.21 | awaiting T+5 | — | $13.75 (+4.09%) |
Oct 23, 2026 3d ago | 6-K | $13.21 | awaiting T+5 | — | $13.75 (−4.09%) |
Oct 21, 2026 5d ago | 6-K | $13.19 | awaiting T+5 | — | $13.75 (+4.25%) |
Oct 14, 2026 12d ago | 6-K | $12.75 $13.19 | ▲ +3.45% | ▲ +3.00% | $13.75 (+7.84%) |
Oct 8, 2026 18d ago | 6-K | $12.20 $12.90 | ▲ +5.74% | ▲ +6.01% | $13.75 (+12.70%) |
Oct 7, 2026 19d ago | 6-K | $12.27 $12.75 | ▲ +3.91% | ▲ +4.89% | $13.75 (+12.06%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers